Authors
This author initiated 53 original pathways:
This author contributed to 405 pathways:
This author contributed to 405 pathways:
Fehrhart
- GitHub: fehrhart
- ORCiD: 0000-0002-7770-620X
- Wikidata: Q28025534
Communities
Adverse Outcome Pathways COVID-19 Rare DiseasesPathways
This author initiated 53 original pathways:
This author contributed to 405 pathways:
This author contributed to 405 pathways:
- Metabolic pathway of LDL, HDL and TG, including diseases - WP4522 (Homo sapiens)
- PCSK9-mediated LDL receptor degradation - WP2846 (Homo sapiens)
- Heterochronic gene regulation of development - WP2227 (Caenorhabditis elegans)
- Cell engulfment - WP2226 (Caenorhabditis elegans)
- Pentose phosphate metabolism - WP134 (Homo sapiens)
- Development of ureteric derived collecting system - WP5053 (Homo sapiens)
- GDNF/RET signaling axis - WP4830 (Homo sapiens)
- COVID-19 adverse outcome pathway - WP4891 (Homo sapiens)
- Arsenic metabolism and reactive oxygen species generation - WP5233 (Homo sapiens)
- Nucleotide excision repair in xeroderma pigmentosum - WP5114 (Homo sapiens)
- Familial hyperlipidemia type 2 - WP5109 (Homo sapiens)
- Neuroinflammation and glutamatergic signaling - WP5083 (Homo sapiens)
- Estradiol regulation in porto-sinusoidal vascular disease - WP5235 (Homo sapiens)
- Chromosomal and microsatellite instability in colorectal cancer - WP4216 (Homo sapiens)
- Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling - WP3612 (Homo sapiens)
- Focal adhesion - WP306 (Homo sapiens)
- Glucocorticoid receptor pathway - WP2880 (Homo sapiens)
- 3q29 copy number variation syndrome - WP4906 (Homo sapiens)
- Endoplasmic reticulum stress response in coronavirus infection - WP4861 (Homo sapiens)
- Neovascularization processes - WP4331 (Homo sapiens)
- Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling - WP3850 (Homo sapiens)
- Vitamin B12 metabolism - WP1533 (Homo sapiens)
- Selenium metabolism / selenoproteins - WP108 (Mus musculus)
- Ovarian infertility - WP34 (Homo sapiens)
- GPR143 in melanocytes and retinal pigment epithelium cells - WP4941 (Homo sapiens)
- CAMKK2 pathway - WP4874 (Homo sapiens)
- Sudden infant death syndrome (SIDS) susceptibility pathways - WP706 (Homo sapiens)
- Canonical and non-canonical TGF-B signaling - WP3874 (Homo sapiens)
- HIF1A and PPARG in cardiac hypertropthy - WP2456 (Homo sapiens)
- Calcium regulation in cardiac cells - WP536 (Homo sapiens)
- MAPK pathway in congenital thyroid cancer - WP4928 (Homo sapiens)
- Ciliary landscape - WP4352 (Homo sapiens)
- ncRNAs involved in STAT3 signaling in hepatocellular carcinoma - WP4337 (Homo sapiens)
- ncRNAs in Wnt signaling in hepatocellular carcinoma - WP4336 (Homo sapiens)
- Thermogenesis - WP4321 (Homo sapiens)
- 16p11.2 proximal deletion syndrome - WP4949 (Homo sapiens)
- Major receptors targeted by epinephrine and norepinephrine - WP4589 (Homo sapiens)
- Cancer immunotherapy by PD-1 blockade - WP4585 (Homo sapiens)
- MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement - WP4560 (Homo sapiens)
- Genes related to primary cilium development (based on CRISPR) - WP4536 (Homo sapiens)
- Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms - WP4534 (Homo sapiens)
- Intraflagellar transport proteins binding to dynein - WP4532 (Homo sapiens)
- Cysteine and methionine catabolism - WP4504 (Homo sapiens)
- Signal transduction through IL1R - WP4496 (Homo sapiens)
- Estrogen receptor pathway - WP2881 (Homo sapiens)
- Network map of SARS-CoV-2 signaling - WP5115 (Homo sapiens)
- Proximal tubule transport - WP4917 (Homo sapiens)
- SARS coronavirus and innate immunity - WP4912 (Homo sapiens)
- Purinergic signaling - WP4900 (Homo sapiens)
- Mammalian disorder of sexual development - WP4842 (Homo sapiens)
- NPHP1 deletion syndrome - WP5399 (Homo sapiens)
- TAR syndrome - WP5362 (Homo sapiens)
- Kleefstra syndrome - WP5351 (Homo sapiens)
- 2q37 copy number variation syndrome - WP5224 (Homo sapiens)
- 2q13 copy number variation syndrome - WP5222 (Homo sapiens)
- 15q13.3 copy number variation syndrome - WP4942 (Homo sapiens)
- 15q11.2 copy number variation syndrome - WP4940 (Homo sapiens)
- 7q11.23 copy number variation syndrome - WP4932 (Homo sapiens)
- Unfolded protein response - WP4925 (Homo sapiens)
- 1q21.1 copy number variation syndrome - WP4905 (Homo sapiens)
- Peroxiredoxin 2 induced ovarian failure - WP4873 (Homo sapiens)
- Regucalcin in proximal tubule epithelial kidney cells - WP4838 (Homo sapiens)
- Prader-Willi and Angelman syndrome - WP3998 (Homo sapiens)
- 8q11.23 (RB1CC1) copy number variation - WP5412 (Homo sapiens)
- 15q25 copy number variation - WP5408 (Homo sapiens)
- 15q11q13 copy number variation - WP5407 (Homo sapiens)
- 13q12.12 copy number variation - WP5406 (Homo sapiens)
- 10q22q23 copy number variation - WP5402 (Homo sapiens)
- 5q35 copy number variation - WP5380 (Homo sapiens)
- 17p13.3 (YWHAE) copy number variation - WP5376 (Homo sapiens)
- 4p16.3 copy number variation - WP5365 (Homo sapiens)
- 17q12 copy number variation syndrome - WP5287 (Homo sapiens)
- Cholestasis - WP5238 (Homo sapiens)
- Bardet-Biedl syndrome - WP5234 (Homo sapiens)
- 2q21.1 copy number variation syndrome - WP5223 (Homo sapiens)
- 2q11.2 copy number variation syndrome - WP5221 (Homo sapiens)
- Dravet syndrome - WP5200 (Homo sapiens)
- Spina bifida - WP5150 (Homo sapiens)
- Familial hyperlipidemia type 1 - WP5108 (Homo sapiens)
- Meta pathway lipodystrophy, dyslipidemia and hyperlipidemia - WP5105 (Homo sapiens)
- Nephrogenesis - WP5052 (Homo sapiens)
- Complement system - WP2806 (Homo sapiens)
- Oxidative phosphorylation - WP623 (Homo sapiens)
- Exercise-induced circadian regulation - WP562 (Danio rerio)
- Complement and coagulation cascades - WP558 (Homo sapiens)
- PAFAH1B1 copy number variation - WP5409 (Homo sapiens)
- 13q12 or CRYL1 copy number variation - WP5405 (Homo sapiens)
- 7q11.23 distal copy number variation - WP5401 (Homo sapiens)
- 6q16 copy number variation - WP5400 (Homo sapiens)
- NRXN1 deletion syndrome - WP5398 (Homo sapiens)
- Smith-Magenis and Potocki-Lupski syndrome copy number variation - WP5381 (Homo sapiens)
- NF1 copy number variation syndrome - WP5366 (Homo sapiens)
- 11p11.2 copy number variation syndrome - WP5348 (Homo sapiens)
- 8p23.1 copy number variation syndrome - WP5346 (Homo sapiens)
- 1p36 copy number variation syndrome - WP5345 (Homo sapiens)
- Kynurenine pathway and links to cell senescence - WP5044 (Homo sapiens)
- Pentose phosphate pathway in senescent cells - WP5043 (Homo sapiens)
- SARS-CoV-2 innate immunity evasion and cell-specific immune response - WP5039 (Homo sapiens)
- Overlap between signal transduction pathways contributing to LMNA laminopathies - WP4879 (Homo sapiens)
- Influence of laminopathies on Wnt signaling - WP4844 (Homo sapiens)
- Peroxiredoxin 2 induced ovarian failure - WP4835 (Mus musculus)
- Vitamin D-sensitive calcium signaling in depression - WP4698 (Homo sapiens)
- Joubert syndrome - WP4656 (Homo sapiens)
- FOXP3 in COVID-19 - WP5063 (Homo sapiens)
- Mitochondrial immune response to SARS-CoV-2 - WP5038 (Homo sapiens)
- Aspirin and miRNAs - WP4707 (Homo sapiens)
- Fragile X syndrome - WP4549 (Homo sapiens)
- Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism - WP4523 (Homo sapiens)
- Rett syndrome - WP4312 (Homo sapiens)
- Acute viral myocarditis - WP4298 (Homo sapiens)
- Purine metabolism and related disorders - WP4224 (Homo sapiens)
- Angiopoietin-like protein 8 regulatory pathway - WP3915 (Homo sapiens)
- Pluripotent stem cell differentiation pathway - WP2848 (Homo sapiens)
- Hair follicle development: cytodifferentiation - stage 3 of 3 - WP2840 (Homo sapiens)
- DNA damage response (only ATM dependent) - WP710 (Homo sapiens)
- Androgen receptor network in prostate cancer - WP2263 (Homo sapiens)
- Familial hyperlipidemia type 3 - WP5110 (Homo sapiens)
- Vitamin A and carotenoid metabolism - WP716 (Homo sapiens)
- RAC1/PAK1/p38/MMP2 pathway - WP3303 (Homo sapiens)
- Folate metabolism - WP176 (Homo sapiens)
- Phosphodiesterases in neuronal function - WP4222 (Homo sapiens)
- Polycystic kidney disease pathway - WP2571 (Homo sapiens)
- miRNA regulation of prostate cancer signaling - WP3981 (Homo sapiens)
- Hippo signaling regulation - WP4540 (Homo sapiens)
- Pilocytic astrocytoma - WP2253 (Homo sapiens)
- ErbB signaling - WP673 (Homo sapiens)
- IL2 signaling - WP49 (Homo sapiens)
- MAP3K1 role in promoting and blocking gonadal determination - WP4872 (Homo sapiens)
- Netrin-UNC5B signaling - WP4747 (Homo sapiens)
- Regulatory circuits of STAT3 signaling - WP4538 (Homo sapiens)
- IL10 anti-inflammatory signaling - WP4495 (Homo sapiens)
- Wnt signaling - WP363 (Homo sapiens)
- Corticotropin-releasing hormone signaling - WP2355 (Homo sapiens)
- Glioblastoma signaling - WP2261 (Homo sapiens)
- PI3K-AKT-mTOR signaling and therapeutic opportunities in prostate cancer - WP3844 (Homo sapiens)
- Prion disease pathway - WP3995 (Homo sapiens)
- Perturbations to host-cell autophagy, induced by SARS-CoV-2 proteins - WP4936 (Homo sapiens)
- STING pathway in Kawasaki-like disease and COVID-19 - WP4961 (Homo sapiens)
- Lipids measured in liver metastasis from breast cancer - WP4627 (Mus musculus)
- Modified nucleosides derived from tRNA as urinary cancer markers - WP4485 (Homo sapiens)
- Degradation pathway of sphingolipids, including diseases - WP4153 (Homo sapiens)
- MicroRNA for targeting cancer growth and vascularization in glioblastoma - WP3593 (Homo sapiens)
- Mecp2 and associated Rett syndrome - WP2910 (Mus musculus)
- Thiamine metabolic pathways - WP4297 (Homo sapiens)
- Markers of kidney cell lineage - WP5236 (Homo sapiens)
- Selective expression of chemokine receptors during T-cell polarization - WP4494 (Homo sapiens)
- Ethanol metabolism production of ROS by CYP2E1 - WP4269 (Homo sapiens)
- Ethanol metabolism resulting in production of ROS by CYP2E1 - WP4268 (Rattus norvegicus)
- Hematopoietic stem cell differentiation - WP2849 (Homo sapiens)
- RAS and bradykinin pathways in COVID-19 - WP4969 (Homo sapiens)
- Downregulation of ACE2 by SARS-CoV-2 spike protein - WP4799 (Homo sapiens)
- Physiological and pathological hypertrophy of the heart - WP1528 (Homo sapiens)
- Hypothesized pathways in pathogenesis of cardiovascular disease - WP3668 (Homo sapiens)
- Multiple epiphyseal dysplasia and pseudoachondroplasia genes - WP4789 (Homo sapiens)
- Alstrom syndrome - WP5202 (Homo sapiens)
- Envelope proteins and their potential roles in EDMD physiopathology - WP4535 (Homo sapiens)
- Effect of progerin on genes involved in progeria - WP4320 (Homo sapiens)
- Lamin A processing pathway - WP4299 (Homo sapiens)
- 10q11.21q11.23 copy number variation syndrome - WP5352 (Homo sapiens)
- Kisspeptin/kisspeptin receptor system in the ovary - WP4871 (Homo sapiens)
- Thyroid hormones production and peripheral downstream signaling effects - WP4746 (Homo sapiens)
- 22q11.2 copy number variation syndrome - WP4657 (Homo sapiens)
- FABP4 in ovarian cancer - WP4400 (Homo sapiens)
- Model for regulation of MSMP expression in cancer cells and its proangiogenic role in ovarian tumors - WP4397 (Homo sapiens)
- Epithelial to mesenchymal transition in colorectal cancer - WP4239 (Homo sapiens)
- miRNA regulation of p53 pathway in prostate cancer - WP3982 (Homo sapiens)
- Photodynamic therapy-induced NF-kB survival signaling - WP3617 (Homo sapiens)
- Flowering time pathway - WP4339 (Brassica napus)
- Oxytocin signaling - WP2889 (Homo sapiens)
- Flowering time pathway - WP2625 (Hordeum vulgare)
- One-carbon metabolism - WP241 (Homo sapiens)
- Host-pathogen interaction of human coronaviruses - interferon induction - WP4880 (Homo sapiens)
- Breast cancer pathway - WP4262 (Homo sapiens)
- TCA cycle nutrient use and invasiveness of ovarian cancer - WP2868 (Homo sapiens)
- 4-hydroxytamoxifen, dexamethasone, and retinoic acids regulation of p27 expression - WP3879 (Homo sapiens)
- Regulation of apoptosis by parathyroid hormone-related protein - WP3872 (Homo sapiens)
- Striated muscle contraction pathway - WP383 (Homo sapiens)
- Amplification and expansion of oncogenic pathways as metastatic traits - WP3678 (Homo sapiens)
- Endometrial cancer - WP4155 (Homo sapiens)
- Alternative pathway of fetal androgen synthesis - WP4524 (Homo sapiens)
- Cholesterol biosynthesis with skeletal dysplasias - WP4804 (Homo sapiens)
- Oxysterols derived from cholesterol - WP4545 (Homo sapiens)
- Disorders of folate metabolism and transport - WP4259 (Homo sapiens)
- Bladder cancer - WP2828 (Homo sapiens)
- Riboflavin and CoQ disorders - WP5037 (Homo sapiens)
- Linoleic acid metabolism affected by SARS-CoV-2 - WP4853 (Homo sapiens)
- Vitamin B6-dependent and responsive disorders - WP4228 (Homo sapiens)
- Genetic causes of porto-sinusoidal vascular disease - WP5269 (Homo sapiens)
- Acquired partial lipodystrophy / Barraquer-Simons syndrome - WP5104 (Homo sapiens)
- 16p11.2 distal deletion syndrome - WP4950 (Homo sapiens)
- Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway - WP4577 (Homo sapiens)
- Biotin metabolism - WP1631 (Mycobacterium tuberculosis)
- miRNA targets in ECM and membrane receptors - WP2911 (Homo sapiens)
- Parkinson's disease pathway - WP2371 (Homo sapiens)
- Creatine pathway - WP5190 (Homo sapiens)
- Ethylmalonic encephalopathy - WP5030 (Homo sapiens)
- Urea cycle and associated pathways - WP4595 (Homo sapiens)
- Urea cycle and related diseases - WP4571 (Homo sapiens)
- Glycosylation and related congenital defects - WP4521 (Homo sapiens)
- Gamma-glutamyl cycle for the biosynthesis and degradation of glutathione, including diseases - WP4518 (Homo sapiens)
- Methionine metabolism leading to sulfur amino acids and related disorders - WP4292 (Homo sapiens)
- MTHFR deficiency - WP4288 (Homo sapiens)
- Vitamin B12 disorders - WP4271 (Homo sapiens)
- Krebs cycle disorders - WP4236 (Homo sapiens)
- Pyrimidine metabolism and related diseases - WP4225 (Homo sapiens)
- GABA metabolism (aka GHB) - WP4157 (Homo sapiens)
- MECP2 and associated Rett syndrome - WP3584 (Homo sapiens)
- Cholesterol synthesis disorders - WP5193 (Homo sapiens)
- Calcium mediated T-cell apoptosis involved in inclusion body myositis - WP5142 (Homo sapiens)
- Proline and hydroxyproline pathways - WP5026 (Homo sapiens)
- Cerebral organic acidurias, including diseases - WP4519 (Homo sapiens)
- Tyrosine metabolism and related disorders - WP4506 (Homo sapiens)
- Biosynthesis and regeneration of tetrahydrobiopterin and catabolism of phenylalanine - WP4156 (Homo sapiens)
- Codeine and morphine metabolism - WP1604 (Homo sapiens)
- Phase I biotransformations, non-P450 - WP1213 (Equus caballus)
- Cancer immunotherapy by CTLA4 blockade - WP4582 (Homo sapiens)
- Amyotrophic lateral sclerosis (ALS) - WP2447 (Homo sapiens)
- Cholesterol biosynthesis pathway - WP197 (Homo sapiens)
- Apoptosis modulation and signaling - WP1772 (Homo sapiens)
- KCNQ2-related epilepsies - WP5360 (Homo sapiens)
- Glycolysis and gluconeogenesis - WP534 (Homo sapiens)
- Synaptic vesicle pathway - WP2267 (Homo sapiens)
- Alzheimer's disease and miRNA effects - WP2059 (Homo sapiens)
- Tryptophan metabolism - WP79 (Mus musculus)
- RIOK1 and RIOK2 in EGFR- and PI3K-mediated tumorigenesis - WP3873 (Homo sapiens)
- Glycine metabolism, including IMDs - WP5028 (Homo sapiens)
- MYD88 distinct input-output pathway - WP3877 (Homo sapiens)
- Sterol regulatory element-binding proteins (SREBP) signaling - WP1982 (Homo sapiens)
- Metapathway biotransformation Phase I and II - WP702 (Homo sapiens)
- Non-small cell lung cancer - WP4255 (Homo sapiens)
- Hematopoietic stem cell gene regulation by GABP alpha/beta complex - WP3657 (Homo sapiens)
- Purine metabolism - WP2185 (Mus musculus)
- Glycolysis in senescence - WP5049 (Homo sapiens)
- Kallmann syndrome - WP5074 (Homo sapiens)
- Primary ovarian insufficiency - WP5316 (Homo sapiens)
- lncRNA in canonical Wnt signaling and colorectal cancer - WP4258 (Homo sapiens)
- Small cell lung cancer - WP4658 (Homo sapiens)
- Wnt signaling - WP428 (Homo sapiens)
- Cell cycle - WP179 (Homo sapiens)
- EGFR tyrosine kinase inhibitor resistance - WP4806 (Homo sapiens)
- PDGFR-beta pathway - WP3972 (Homo sapiens)
- MFAP5-mediated ovarian cancer cell motility and invasiveness - WP3301 (Homo sapiens)
- Genetic alterations of lung cancer - WP1968 (Rattus norvegicus)
- Nuclear receptors meta-pathway - WP2882 (Homo sapiens)
- Pre-implantation embryo - WP3527 (Homo sapiens)
- MicroRNAs in cardiomyocyte hypertrophy - WP1544 (Homo sapiens)
- Fluoropyrimidine activity - WP1601 (Homo sapiens)
- Parkinson's disease - WP3638 (Mus musculus)
- Photosynthetic carbon reduction - WP1461 (Arabidopsis thaliana)
- Notch signaling - WP268 (Homo sapiens)
- mRNA processing - WP411 (Homo sapiens)
- Myometrial relaxation and contraction pathways - WP289 (Homo sapiens)
- Intracellular trafficking of CFTR - WP1486 (Rattus norvegicus)
- Glycogen synthesis and degradation - WP500 (Homo sapiens)
- Serotonin HTR1 group and FOS pathway - WP722 (Homo sapiens)
- Serotonin receptor 2 and STAT3 signaling - WP2079 (Mus musculus)
- Osteoclast signaling - WP890 (Pan troglodytes)
- Inclusion body myositis - WP5120 (Homo sapiens)
- Type I interferon induction and signaling during SARS-CoV-2 infection - WP4868 (Homo sapiens)
- Fatty acid biosynthesis - WP38 (Caenorhabditis elegans)
- Fatty acid biosynthesis - WP357 (Homo sapiens)
- Leukotriene metabolic pathway - WP5171 (Homo sapiens)
- GDNF/RET signaling axis - WP4820 (Mus musculus)
- Primary carbon metabolism - WP2859 (Populus trichocarpa)
- Translation factors - WP110 (Caenorhabditis elegans)
- mRNA processing - WP123 (Caenorhabditis elegans)
- Ethanol effects on histone modifications - WP3996 (Homo sapiens)
- TCA cycle in senescence - WP5050 (Homo sapiens)
- Pregnane X receptor pathway - WP2876 (Homo sapiens)
- Myometrial relaxation and contraction pathways - WP385 (Mus musculus)
- mRNA processing - WP310 (Mus musculus)
- COVID-19, thrombosis and anticoagulation - WP4927 (Homo sapiens)
- Overview of nanoparticle effects - WP3287 (Homo sapiens)
- Retinoblastoma gene in cancer - WP3206 (Bos taurus)
- Allograft rejection - WP2328 (Homo sapiens)
- Leukocyte-intrinsic Hippo pathway functions - WP4542 (Homo sapiens)
- DNA IR-damage and cellular response via ATR - WP4016 (Homo sapiens)
- Melatonin metabolism and effects - WP3298 (Homo sapiens)
- SARS-CoV-2 and ACE2 receptor: molecular mechanisms - WP4883 (Homo sapiens)
- LDLRAD4 and what we know about it - WP4904 (Homo sapiens)
- SARS-CoV-2 and COVID-19 pathway - WP4846 (Homo sapiens)
- Photodynamic therapy-induced AP-1 survival signaling - WP3611 (Homo sapiens)
- Serine metabolism - WP4688 (Homo sapiens)
- nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell - WP5027 (Homo sapiens)
- Male infertility - WP4673 (Homo sapiens)
- Parkin-ubiquitin proteasomal system pathway - WP2359 (Homo sapiens)
- Vitamin D receptor pathway - WP2877 (Homo sapiens)
- Tryptophan metabolism - WP465 (Homo sapiens)
- Hereditary leiomyomatosis and renal cell carcinoma pathway - WP4206 (Homo sapiens)
- Host-pathogen interaction of human coronaviruses - MAPK signaling - WP4877 (Homo sapiens)
- Arrhythmogenic right ventricular cardiomyopathy - WP2118 (Homo sapiens)
- Progeria-associated lipodystrophy - WP5103 (Homo sapiens)
- Congenital generalized lipodystrophy - WP5101 (Homo sapiens)
- Genes controlling nephrogenesis - WP4823 (Homo sapiens)
- Distal convoluted tubule 1 (DCT1) cell - WP4183 (Mus musculus)
- NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence - WP5046 (Homo sapiens)
- Ovarian infertility - WP273 (Mus musculus)
- SARS-CoV-2 altering angiogenesis via NRP1 - WP5065 (Homo sapiens)
- Flowering time pathway - WP2603 (Beta vulgaris)
- Polar auxin transport - WP2941 (Arabidopsis thaliana)
- Fatty acid beta-oxidation 3 - WP499 (Caenorhabditis elegans)
- Fatty acid beta-oxidation 2 - WP148 (Caenorhabditis elegans)
- Glycogen metabolism - WP436 (Caenorhabditis elegans)
- Mevalonate arm of cholesterol biosynthesis pathway - WP4190 (Homo sapiens)
- ERK1-ERK2 MAPK cascade - WP402 (Danio rerio)
- Cannabinoid receptor signaling - WP3869 (Homo sapiens)
- Lung fibrosis - WP3624 (Homo sapiens)
- FGF signaling pathway - WP152 (Danio rerio)
- Sphingolipid pathway - WP1422 (Homo sapiens)
- Pentose phosphate pathway - WP1231 (Anopheles gambiae)
- Deregulation of Rab and Rab effector genes in bladder cancer - WP3171 (Bos taurus)
- Nitric oxide metabolism in cystic fibrosis - WP4947 (Homo sapiens)
- Prostaglandin synthesis and regulation - WP374 (Mus musculus)
- Electron transport chain - WP295 (Mus musculus)
- Acetylcholine synthesis - WP264 (Caenorhabditis elegans)
- GPCRs, orphan - WP1398 (Mus musculus)
- Endochondral ossification - WP1270 (Mus musculus)
- Conversion of angiotensinogen to angiotensin II - WP4818 (Homo sapiens)
- Neural crest cell migration in cancer - WP4565 (Homo sapiens)
- lncRNA-mediated mechanisms of therapeutic resistance - WP3672 (Homo sapiens)
- Interactions between LOXL4 and oxidative stress pathway - WP3670 (Homo sapiens)
- Metabolism of dichloroethylene by CYP450 - WP3666 (Homo sapiens)
- Biochemical pathways: part I - WP3604 (Homo sapiens)
- Circadian rhythm genes - WP3594 (Homo sapiens)
- Constitutive androstane receptor pathway - WP2875 (Homo sapiens)
- Diclofenac metabolic pathway - WP2491 (Homo sapiens)
- Gastric cancer network 2 - WP2363 (Homo sapiens)
- Gastric cancer network 1 - WP2361 (Homo sapiens)
- Deregulation of Rab and Rab effector genes in bladder cancer - WP2291 (Homo sapiens)
- Osteoblast signaling - WP956 (Pan troglodytes)
- Monoterpene biosynthesis pathway in mint - WP4701 (Vitis vinifera)
- Fluoropyrimidine activity - WP3275 (Bos taurus)
- TCA cycle nutrient use and invasiveness of ovarian cancer - WP3252 (Bos taurus)
- Thyroid stimulating hormone (TSH) signaling pathway - WP3227 (Bos taurus)
- Gastric cancer network 1 - WP3166 (Bos taurus)
- Polar auxin transport - WP2940 (Oryza sativa)
- Glyoxylate, anapleurotic and succinyl CoA (GAS) pathway - WP2638 (Mycobacterium tuberculosis)
- Tryptophan degradation - WP301 (Saccharomyces cerevisiae)
- Phenylalanine, tyrosine, and tryptophan biosynthesis - WP27 (Saccharomyces cerevisiae)
- P-cymene degradation - WP181 (Saccharomyces cerevisiae)
- Toll, IMD, JAK/STAT pathways for immune response to pathogens - WP3856 (Anopheles gambiae)
- Polyol pathway - WP690 (Homo sapiens)
- GPR40 pathway - WP3958 (Homo sapiens)
- miRNA biogenesis - WP2338 (Homo sapiens)
- Focal adhesion - WP188 (Rattus norvegicus)
- Oxidative stress response - WP1372 (Danio rerio)
- Acetylcholine synthesis - WP476 (Danio rerio)
- Ectoderm differentiation - WP2858 (Homo sapiens)
- FOXA2 pathway - WP5066 (Homo sapiens)
- Host-pathogen interaction of human coronaviruses - apoptosis - WP4864 (Homo sapiens)
- Host-pathogen interaction of human coronaviruses - autophagy - WP4863 (Homo sapiens)
- One-carbon metabolism - WP435 (Mus musculus)
- Metabolism overview - WP3602 (Homo sapiens)
- Retinoblastoma gene in cancer - WP2446 (Homo sapiens)
- Disruption of postsynaptic signaling by CNV - WP4875 (Homo sapiens)
- Somatic sex determination - WP4814 (Homo sapiens)
- BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation - WP3876 (Homo sapiens)
- Phytochrome signaling pathway to turn on photomorphogenesis - WP3662 (Arabidopsis thaliana)
- Oxytocin signaling - WP3222 (Bos taurus)
- Farnesoid X receptor pathway - WP2879 (Homo sapiens)
- PPAR-alpha pathway - WP2878 (Homo sapiens)
- Liver X receptor pathway - WP2874 (Homo sapiens)
- Endoderm differentiation - WP2853 (Homo sapiens)
- Alzheimer's disease - WP2075 (Mus musculus)
- TGF-beta signaling pathway - WP113 (Mus musculus)
- Lung fibrosis - WP3632 (Mus musculus)
- Amino acid conjugation of benzoic acid - WP521 (Homo sapiens)
- Splicing factor NOVA regulated synaptic proteins - WP4148 (Homo sapiens)
- Nanomaterial induced apoptosis - WP2507 (Homo sapiens)
- ErbB signaling pathway - WP1299 (Rattus norvegicus)
- ErbB signaling pathway - WP1261 (Mus musculus)
- Tumor suppressor activity of SMARCB1 - WP4204 (Homo sapiens)
- Corticotropin-releasing hormone - WP3265 (Bos taurus)
- Ultraconserved region 339 modulation of tumor suppressor microRNAs in cancer - WP4284 (Homo sapiens)
- mir-193a and MVP in colon cancer metastasis - WP3979 (Mus musculus)
- miR-509-3p alteration of YAP1/ECM axis - WP3967 (Homo sapiens)
- Tamoxifen metabolism - WP3264 (Bos taurus)
- Apoptosis-related network due to altered Notch3 in ovarian cancer - WP3126 (Bos taurus)
- Apoptosis-related network due to altered Notch3 in ovarian cancer - WP2864 (Homo sapiens)
- Polyol pathway - WP936 (Pan troglodytes)
- Ethanol metabolism resulting in production of ROS by CYP2E1 - WP4265 (Mus musculus)
- Valproic acid pathway - WP3871 (Homo sapiens)
- Cytosine methylation - WP3585 (Homo sapiens)
- PPAR signaling pathway - WP2316 (Mus musculus)
- NRF2 pathway - WP2884 (Homo sapiens)
- Photodynamic therapy-induced HIF-1 survival signaling - WP3614 (Homo sapiens)
- Photodynamic therapy-induced unfolded protein response - WP3613 (Homo sapiens)
- mRNA, protein, and metabolite inducation pathway by cyclosporin A - WP3953 (Homo sapiens)
- Septum site determination - WP3538 (Escherichia coli)
- Tryptophan metabolism - WP3248 (Bos taurus)
- Polyol pathway - WP1375 (Danio rerio)
- Oxidative phosphorylation - WP1335 (Danio rerio)
- Polyol pathway - WP1236 (Anopheles gambiae)
- Polyol pathway - WP1218 (Equus caballus)
- Polyol pathway - WP1170 (Canis familiaris)
- Tryptophan metabolism - WP1126 (Canis familiaris)
- Transcription factor regulation in adipogenesis - WP3599 (Homo sapiens)
- miRNAs and TFs in iPS Cell Generation - WP2375 (Mus musculus)
- Mismatch repair - WP1233 (Anopheles gambiae)
- Tryptophan metabolism - WP270 (Rattus norvegicus)
- Nanoparticle triggered autophagic cell death - WP2509 (Homo sapiens)
- Glyoxylate cycle - WP2566 (Mycobacterium tuberculosis)
- Sleep regulation - WP3591 (Homo sapiens)
- p53 signaling - WP2902 (Mus musculus)
- Peptide GPCRs - WP1338 (Danio rerio)